What is Biogenetics?
Biogenetics Corporation is a specialized entity focused on cryobanking and advanced fertility laboratory services. The company offers comprehensive donor screening and the cryopreservation of reproductive cells and tissues, encompassing sperm, embryos, and ovarian tissue. Their diverse donor programs, including Anonymous, Access, and Total Access ID (T.A.ID), cater to a broad spectrum of client needs, facilitating worldwide distribution of sperm from various ethnic backgrounds. Beyond reproductive services, Biogenetics also provides urology and laboratory diagnostics for male fertility evaluation, serving both prospective donors and recipients. The secure transport and long-term storage of reproductive materials are central to their operational framework.
How much funding has Biogenetics raised?
Biogenetics has raised a total of $72K across 1 funding round:
Debt
$72K
Debt (2021): $72K with participation from PPP
What's next for Biogenetics?
The substantial expansion capital recently acquired by Biogenetics positions the company for significant growth and strategic development. This investment is expected to enhance their service offerings, potentially expanding laboratory capabilities, broadening donor program reach, and strengthening their global distribution network for reproductive materials. As a player in the sensitive and growing field of fertility services and cryopreservation, Biogenetics is poised to leverage this financing to solidify its market leadership and innovate within the reproductive health landscape.
See full Biogenetics company page
